Hydration Pharmaceuticals Company Ltd has released a press release.
Q3 FY24 Quarterly Activities Report (App 4C)
Filed with ASX ·
6ix hasn’t read this filing yet.
Hydration Pharmaceuticals Company Limited on 6ix
Story so far
Earlier from Hydration Pharmaceuticals
- Completion of divesture of non-US assets
- Divesture of Hydralyte's non-US assets
- FY24 Half Year Results Announcement
- Appendix 4D and FY24 Half Year Financial Report
- Q2 FY24 Quarterly Activities Report (App 4C)
Later from Hydration Pharmaceuticals
- US Operations Update
- Q4 FY24 Quarterly Activities Report (App 4C)
- FY24 Appendix 4E
- Strategic Placement and Rights Issue to Raise up to $1.25m
- Amended Rights Issue Timetable
Follow Hydration Pharmaceuticals into a list and get an email when it puts out news.
Follow Hydration Pharmaceuticals